Zepbound is the preferred weight loss medicine vs. Wegovy and has consistently beaten the latter in U.S. weekly prescriptions ...

Rite Aid pointed to continued financial challenges, exacerbated by "rapidly evolving retail and healthcare landscapes," as ...

Following the sell-off, Lilly trades at a forward price-to-earnings (P/E) of 37 times 2025 analyst estimates, with a price-to ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

Vertex has recorded some 25,000 prescriptions for Journavx since its January approval and is in the process of getting big ...

Rite Aid files Chapter 11 again, reflecting deep struggles in the pharmacy industry amid closures, falling margins, and ...

Auto retail sales rose 3% YoY in April to 2.28 million units, driven by festive demand and improved sentiment. Two-wheelers, ...

Aetna, owned by CVS Health, will exit the Affordable Care Act (ACA) marketplace, forcing approximately 1 million ...

GSGDSGPV retail last month stood at 3,49,939 units as compared to 3,44,594 units in April 2024, up 1.55 per cent - FADA.

Retail sales of passenger vehicles (PV) grew 1.5% year-on-year to 3.5 lakh units in April 2025 compared with 3.44 lakh units ...

In this week’s S&P 500 healthcare earnings roundup, 21 of 24 companies beat earnings expectations, while three fell short. On the revenue front, seven missed Wa ...